Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Clinical trial NCT05340491 · RECRUITING

Trial details

NCT number: NCT05340491
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2022-04-01
Primary completion: 2026-12-01
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.